pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-628 |
Genomic Coordinates | chr15: 55372940 - 55373034 |
Synonyms | MIRN628, hsa-mir-628, MIR628 |
Description | Homo sapiens miR-628 stem-loop |
Comment | The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-628-5p | |||||||||||||||||||||||||||
Sequence | 23| AUGCUGACAUAUUUACUAGAGG |44 | |||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||
Experiments | Cloned | DRVs in miRNA |
|
|||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | UBXN2B | ||||||||||||||||||||
Synonyms | p37 | ||||||||||||||||||||
Description | UBX domain protein 2B | ||||||||||||||||||||
Transcript | NM_001077619 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on UBXN2B | |||||||||||||||||||||
3'UTR of UBXN2B (miRNA target sites are highlighted) |
>UBXN2B|NM_001077619|3'UTR 1 TATTGTTCCTGTCCATGCAGTAGCATGTGGGAATAGATGATGTGCCGTATTAATAAGGACAATACTTCAGCATTAAAAAC 81 AGCCAAATTATTTTTATTATTTTTACAGATAAATTTTGGTTTTATTGTTATTCTGTCTTCCAATCTGAATATAGACAAAT 161 TTGGATTAGGAATAGACCTTGAGATAAGTATGTTTGAGTTTTTAGTTGAAGGACTGGCTTATGTTGATAGTTTTTGGATT 241 TCTAGGCAAATGAGTTGTTACATGCTTAGTGTTAATGTAACAACATTTGTTTGCAGAGAAAAATGAACAAAACCCCTTTT 321 TGATAAATGCATTTGGTAAAATTTGCACTAAAGTTTCTTGATGCAGCATTGACCAACAGCCATTAAGAAATCTTTTGATC 401 AAATAAGTTGAAAATTTGTCTATAATATATACTGAAACGTGTCTTTTGATTTTGAAATTGTTTGATCATACAATAATTAT 481 TTCTCCTATTAAGATTTTACACATCCTTTTTACTTACTGATTTAGATATATTACTAGTATCAGAAACTACAGTTTTGCCT 561 TGTATTTTACAGAATTATGACTGTTGTGAACTTAAACAGAAACACATAAAGGTCAGCAATTCTTTTTTTTTTTTTTTTTG 641 ATATGGAGTTTTGCTCTTGTTGCCCAGGCTGGAGTGCAATGGCATAATTTCTGCTCACCGCAACCTCCGCCTCCCAGGTT 721 CAAAAGATTCTCCTGCCTTAGCCTCCCAAGTAGCTGGGATTACAGGCATGCGCCACCATGCCTGGCTAATTTTTGTACTT 801 TTGCTAGAGACAGCGTTTCTCTGTGTTGATCAGGCTGGTCTCGAACTCCGAACCTCAGGTGATCCACCCACCTCAGCCTC 881 CCAAAGTGCTGGGATTACAGGCATGAGCCACCACGCCCAGCCTAAAGGTCAGCAGTTCTTAAGAAGATATGGTAAACAGC 961 AACAATATTTTAAAATCAAGTAATTACAGTTCCTCCCAGAGCTTGCGTTGATCACATTCATTTATTCATTCAACACATTT 1041 TTCTAGGAAACTCACTGTATACACTAAACACTATTCTGTGTGCTCAACCTAGAATGTCTTCTCCAGAACAAGACTAGTGT 1121 AGAAATACAGGAATGTAAATTCTGTCAGACGGACTAGATCTAAAGAATTACCAGCATAAATGTTTGCATTTCTGCTGAAG 1201 CCAGAAGCTTTTCCTTCTTCCTAGACACCATTTCATCCTTAATTATTACTTCTGGTTAGTTTTCCATTGCCACCATAACA 1281 AGTTACAAAATGTGGCTTAAAATAGCACAAATTTATTATCTTCACAATTCTGTAGGTTAGGAGTCCAGGTTAAGAGTTTC 1361 GCGGTGCCAAGATCAATTTGTTGGCAGGGTTGCATTCTGTTAGGAGGCTCTACAGGAGAATCATTTCCTTGTCATTCCAC 1441 CTTCTACAGGACATCCTCATTCCTTGGCTTGTGACCTCCTTCTTCCATCTTAAAAACCAGTGCTGTTTCATCTCTATGAC 1521 CCTTCTGTTACCACATCTCTCTGACACCAGTGTGGAGAGGTTCTCTGCAGGACTCATGATTAAATGAGGCCCACCGGATA 1601 TCCAATCTAGGCTTATCTCCTTGTCTTGAAATCCATAGTAACCTTAATTACATCTGCAAAATCTCTTTTACCATCTAAGG 1681 TTACATACAGGTTTGGAGATTAGGACATTAACATTTTACATGGAACATTATTCTTGCCTACTACAGTTCCCACCCACCCC 1761 CCGCTCCACTCCTGTGTTAAAGATTCAGATTCATCACAAATAAATTTACATCACTCATAGGTGCTCAAAAGTCACAATCC 1841 ATTATTACAGCATCAACTCTAAATCCAAAATCTTATCTGAGTCTCACCAACTCAAAAGTCTCAAATCTCACATTGAAGCC 1921 ATCTAAATTAAGTTTGGGAGAGGATCTGTGTGTGATTTCTGGGACATAATTCCAACTGTGCACTTGTGAACCTAGAAAAC 2001 AAGTTATCTGTTCCCAAGTATGATGGCATGACAGGCAGACAATAATAGTTACACACGTTCCTGTTCAAAAAGCAGAAACA 2081 GATGGAAAAAGGAGCCATCAGCACCAATCAATTTACAAAACCAGCGAGGCACCCTTCTTTAAGTTTCAAGGCCTGGGAGT 2161 AATCTTCAGCTCACTGCTGTTCTCTGGGCTTGTTGACTGTCTCAGAGTCATCTTTACTTTTTCACAAAAGGTAGCACACG 2241 TTTGCAGCTGAGTATCAACTTATCAGTTTGTTCTTCTTTTATATTCTCTAAAGCTTTCTGTTAAAAATGGTGGTGCTTCT 2321 GCTGCTATAACGTTGTCAAGAAACTTGTGGGTCTTTTACATATGTCACAGGGATGCACTCATTTAGATAGGAGGCTCCTC 2401 ACGTATCTTTCCTGGAAAATCCTGTCTCTGTTTTTGGCTTTTTCTGAAATAGCTGAGAGGATCTATGATTCACACCCTTA 2481 ATATCTTCAAAGAGTCTTGTGTGTGACCTGATATTCAGACCTTTTGATGTTTCTGAAGTATTAGCAAAAGGTTATACAGC 2561 CATATCTTCATCACTTTCTCTAGAGTAAAGGCTGTCCTGACGGTGAATCTTAGTTTTAGTGGCTTTTGCCATTTGAATAG 2641 GCCGCGAATTTCCCAAATCATCAAGTCCTGGTTTCTTTATATTTAACAGGTCTTCCCTCAATCTACCTCTTTCCACATTT 2721 TACTATAATCAGCAAGAAGACAGCAGGCTGTACCTTCCACAGCTTGCTTGGAAATATCCTCAGCTAAATATTGAAGTCAT 2801 CACTTAAAAGTTCTGCTTTACACATAACGGCAGGACACAACTCAGCTTAGCTTTTCGCCACTATGTAACAAGGACTCCTT 2881 TCCTCCACTTCTCCAGTAACATATTCCTCATTTTTTACCAACAGTCTATTCATGATGATTTAGATATTCTATGGCAATCG 2961 AGGTATTCTCTATTATGCTCCTTTCTTCAAGGCCGCCCTAGCATTAACATTCCATATTTCTACTAACAGTCTGTTTAAGG 3041 CAGTTTAGCTTCTTTTCTGGCATGCTCCTCAGAATTCTTCCAGCCTCCACCTACTGCCCAATTCCAGAGCCACTTTTCTA 3121 CTTTTAGGTATTTGTTACAGCAGCACCTCAAGTACCTAGAAAACTCTTTTATGCCTGCTTCTCTGCCAGATGACTTGAAT 3201 ATGGTACTAGATTTGGAATTCACCTTTCTCCAGGGTCACTGTTTATTTCAAAGAGGTGAATTTACCTGTGCTAGGGTTTT 3281 CACACTGGGAGTGCTACCAGAACTACCACAGGATGAAAGTGGTGAGCCCACCACTGCAGAGAAGTTTTCTCAGTGCCGTA 3361 ATATAGAGGAATTCTCAAAATAAGCCCTACTCCTTTTCACTTACTGAAAACAACTTGGATAATGTGTAACAGCCAGCCCC 3441 ATTTCAAAAAGATTACCAGGGGTAAAACAACTTTTTCATGGGTCAAAATCATCTTCCGAAGAAAATGATTTCTTAAAAGA 3521 ATTGAACATTGTAAATCAAAGGGCATTGTCCTGTTTTGGATTAACAAAACAGGAAAAATAACCAATCCTTGTAAAATTAT 3601 TTGAAATTTTCTTGTTTTTATCAGTTGAGTGCCTATAGATGCACATACAAAAACAACTGCCATTTTTGTATATAATAGTC 3681 TTCCAAGATAGAGATTTACATTAGGAGAGAATTAAACATCCAGGAGGGATGAACAGTATTTCATGTGTGCTATGTAGTGT 3761 TTTGCTTCATTGAGAGTCATTTTCATGAATTATTTTTACTACTGCAGTCATCTTAAATTTATAATCATCTCAAAAAAGAT 3841 GTCACAATGAACAGACAACCATCTGTGAGGTCAGTCATTTTGCATGATGTATGTAATCAAAAAGTTTGAAATGTCTGCTT 3921 ACTAATAAAGAATGTTTTCACTGAAACTTAAAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 137886.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
CLIP-seq Support 1 for dataset GSM4903828 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / PID21_9124 |
Location of target site | NM_001077619 | 3UTR | AAGAAGACAGCAGGCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161237 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM714645 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000399598.2 | 3UTR | UCAAUCUACCUCUUUCCACAUUUUACUAUAAUCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
44 hsa-miR-628-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT037783 | NELFE | negative elongation factor complex member E | 1 | 1 | ||||||||
MIRT200944 | ZNF264 | zinc finger protein 264 | 2 | 6 | ||||||||
MIRT441916 | ACADSB | acyl-CoA dehydrogenase, short/branched chain | 2 | 2 | ||||||||
MIRT443436 | PLSCR1 | phospholipid scramblase 1 | 2 | 2 | ||||||||
MIRT443447 | CLIC5 | chloride intracellular channel 5 | 2 | 2 | ||||||||
MIRT443906 | ZNF256 | zinc finger protein 256 | 2 | 2 | ||||||||
MIRT449750 | SMYD2 | SET and MYND domain containing 2 | 2 | 2 | ||||||||
MIRT461377 | SLFN12L | schlafen family member 12 like | 2 | 2 | ||||||||
MIRT466416 | TFAP2A | transcription factor AP-2 alpha | 2 | 8 | ||||||||
MIRT486594 | CTPS2 | CTP synthase 2 | 2 | 2 | ||||||||
MIRT491945 | VPS52 | VPS52, GARP complex subunit | 2 | 2 | ||||||||
MIRT513492 | SSR1 | signal sequence receptor subunit 1 | 2 | 6 | ||||||||
MIRT528599 | ZNF326 | zinc finger protein 326 | 2 | 2 | ||||||||
MIRT531325 | SEMA3D | semaphorin 3D | 2 | 2 | ||||||||
MIRT532082 | RTTN | rotatin | 2 | 2 | ||||||||
MIRT532563 | CSTF1 | cleavage stimulation factor subunit 1 | 2 | 2 | ||||||||
MIRT532976 | ZNF12 | zinc finger protein 12 | 2 | 2 | ||||||||
MIRT534075 | SREK1IP1 | SREK1 interacting protein 1 | 2 | 2 | ||||||||
MIRT536103 | MBNL1 | muscleblind like splicing regulator 1 | 2 | 4 | ||||||||
MIRT536183 | MAOB | monoamine oxidase B | 2 | 2 | ||||||||
MIRT543755 | UBXN2B | UBX domain protein 2B | 2 | 2 | ||||||||
MIRT550000 | KIAA0408 | KIAA0408 | 2 | 2 | ||||||||
MIRT551237 | COLEC10 | collectin subfamily member 10 | 2 | 2 | ||||||||
MIRT567554 | FEN1 | flap structure-specific endonuclease 1 | 2 | 2 | ||||||||
MIRT570387 | UBE2D4 | ubiquitin conjugating enzyme E2 D4 (putative) | 2 | 2 | ||||||||
MIRT570808 | LYN | LYN proto-oncogene, Src family tyrosine kinase | 2 | 2 | ||||||||
MIRT576346 | Pxdn | peroxidasin | 2 | 2 | ||||||||
MIRT576520 | Txlna | taxilin alpha | 2 | 2 | ||||||||
MIRT576893 | Poteg | POTE ankyrin domain family, member G | 2 | 2 | ||||||||
MIRT606796 | BICD2 | BICD cargo adaptor 2 | 2 | 2 | ||||||||
MIRT625909 | GBP6 | guanylate binding protein family member 6 | 2 | 2 | ||||||||
MIRT626869 | PDGFRA | platelet derived growth factor receptor alpha | 2 | 2 | ||||||||
MIRT643603 | IRAK4 | interleukin 1 receptor associated kinase 4 | 2 | 2 | ||||||||
MIRT645451 | FOXE1 | forkhead box E1 | 2 | 2 | ||||||||
MIRT652265 | TOMM20 | translocase of outer mitochondrial membrane 20 | 2 | 2 | ||||||||
MIRT689023 | ARID1A | AT-rich interaction domain 1A | 2 | 2 | ||||||||
MIRT691057 | CRCP | CGRP receptor component | 2 | 2 | ||||||||
MIRT704712 | CHD9 | chromodomain helicase DNA binding protein 9 | 2 | 2 | ||||||||
MIRT713069 | ENTHD1 | ENTH domain containing 1 | 2 | 2 | ||||||||
MIRT719483 | RBM27 | RNA binding motif protein 27 | 2 | 2 | ||||||||
MIRT732944 | AGAP2-AS1 | AGAP2 antisense RNA 1 | 3 | 0 | ||||||||
MIRT732945 | KLF12 | Kruppel like factor 12 | 3 | 0 | ||||||||
MIRT733520 | BMP2 | bone morphogenetic protein 2 | 3 | 0 | ||||||||
MIRT733521 | ETV1 | ETS variant 1 | 3 | 0 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|